Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma

被引:34
作者
Humbert, Michael
Antoni, Sascha
Brill, Boris
Landersz, Margot
Rodes, Berta
Soriano, Vicente
Wintergerst, Uwe
Knechten, Heribert
Staszewski, Schlomo
von Laer, Dorothee
Dittmar, Matthias T.
Dietrich, Ursula
机构
[1] Inst Biomed Res, D-60569 Frankfurt, Germany
[2] Hosp Carlos III, Dept Infect Dis, Madrid, Spain
[3] Kinderspital, Immundefekt Ambulanz, Munich, Germany
[4] Praxiszentrum Blondelstr, Aachen, Germany
[5] JW Goethe Univ Hosp, Div Infect Dis, Frankfurt, Germany
[6] Inst Hyg, Dept Virol, Heidelberg, Germany
关键词
HIV-1; long-term non-progressors; mimotopes; neutralization; phage display;
D O I
10.1002/eji.200636560
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A promising approach to identify HIV-1 vaccine candidates is to dissect the natural immune response against the virus in persons controlling the infection over decades without any antiviral therapy. Here we focus on a group of such persons, eight long-term non-progressors (LTNP), in which we proved the presence of broadly neutralizing antibodies against HIV-1 in the plasma as very likely cause for their LTNP status. The aim of this study was to identify the epitopes for these neutralizing antibodies, as these should represent immunogens potentially able to elicit neutralizing antibodies upon vaccination. We screened random peptide phage libraries with plasma antibodies from eight LTNP. After several rounds of positive and negative selection, about 700 HIV-specific mimotopes were sequenced. The mimotope sequences were analyzed for homology to HIV-1 Env, in particular for their capacity to represent conformational epitopes on the surface of the gp120 structure using our software 3DEX. Related phage groups were analyzed for crossreactivity with the LTNP plasma by ELISA as well as for their capacity to induce HIV-1-neutralizing antibodies in mice. Based on this study interesting mimotopes can now be selected for further immunization studies.
引用
收藏
页码:501 / 515
页数:15
相关论文
共 49 条
  • [1] Phage display technology: clinical applications and recent innovations
    Azzazy, HME
    Highsmith, WE
    [J]. CLINICAL BIOCHEMISTRY, 2002, 35 (06) : 425 - 445
  • [2] Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells
    Beirnaert, E
    De Zutter, S
    Janssens, W
    van der Groen, G
    [J]. VIROLOGY, 2001, 281 (02) : 305 - 314
  • [3] ANTIGENIC IMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE QUATERNARY STRUCTURE - OLIGOMER-SPECIFIC AND OLIGOMER-SENSITIVE MONOCLONAL-ANTIBODIES
    BRODER, CC
    EARL, PL
    LONG, D
    ABEDON, ST
    MOSS, B
    DOMS, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) : 11699 - 11703
  • [4] Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
    Broliden, K
    Hinkula, J
    Devito, C
    Kiama, P
    Kimani, J
    Trabbatoni, D
    Bwayo, JJ
    Clerici, M
    Plummer, F
    Kaul, R
    [J]. IMMUNOLOGY LETTERS, 2001, 79 (1-2) : 29 - 36
  • [5] HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men
    Buchacz, K
    Parekh, BS
    Padian, NS
    Van der Straten, A
    Phillips, S
    Jonte, J
    Holmberg, SD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (18) : 1689 - 1693
  • [6] HIV vaccine design and the neutralizing antibody problem
    Burton, DR
    Desrosiers, RC
    Doms, RW
    Koff, WC
    Kwong, PD
    Moore, JP
    Nabel, GJ
    Sodroski, J
    Wilson, IA
    Wyatt, RT
    [J]. NATURE IMMUNOLOGY, 2004, 5 (03) : 233 - 236
  • [7] VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    CAO, YZ
    QIN, LM
    ZHANG, LQ
    SAFRIT, J
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 201 - 208
  • [8] Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection
    Carotenuto, P
    Looij, D
    Keldermans, L
    de Wolf, F
    Goudsmit, J
    [J]. AIDS, 1998, 12 (13) : 1591 - 1600
  • [9] A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects
    Cecilia, D
    Kleeberger, C
    Muñoz, A
    Giorgi, JV
    Zolla-Pazner, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06) : 1365 - 1374
  • [10] Aids vaccines: Back to 'plan A'
    Check, E
    [J]. NATURE, 2003, 423 (6943) : 912 - 914